Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Frank Haluska
Safety and Preliminary Efficacy Analysis of the mTOR Inhibitor Ridaforolimus in Patients With Taxane-Treated, Castration-Resistant Prostate Cancer
Clinical Genitourinary Cancer
Oncology
Urology
Related publications
Abiraterone in Metastatic Castration-Resistant Prostate Cancer: Efficacy and Safety in Unselected Patients
Cancer Treatment and Research Communications
Cancer Research
Oncology
Synergistic Activity of the mTOR Inhibitor Ridaforolimus and the Antiandrogen Bicalutamide in Prostate Cancer Models
International Journal of Oncology
Cancer Research
Oncology
PKM2 Under Hypoxic Environment Causes Resistance to mTOR Inhibitor in Human Castration Resistant Prostate Cancer
Oncotarget
Oncology
Analysis of Overall Survival in Patients With Nonmetastatic Castration-Resistant Prostate Cancer Treated With Vaccine, Nilutamide, and Combination Therapy
Clinical Cancer Research
Cancer Research
Oncology
Pcn336 - Treatment of Metastatic Castration-Resistant Prostate Cancer Patients Previously Treated With Docetaxel in Portugal
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Circulating Tumor Cell Analysis in Patients With Progressive Castration-Resistant Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
Pcn346 - Disease Specific Cost Analysis of the Nonmetastatic Castration-Resistant Prostate Cancer and Metastatic Castration-Resistant Prostate Cancer Health States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Docetaxel Rechallenge in Patients With Castration-Resistant Prostate Cancer — A Review
European Oncology and Haematology
Oncology
Hematology
Higher Incidence of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Castration Resistant Prostate Cancer Treated With Anti-Angiogenic Agents
Cancer Investigation
Medicine
Cancer Research
Oncology
